Meixia Bi

2.1k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Meixia Bi is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Meixia Bi has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Meixia Bi's work include Cancer, Hypoxia, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meixia Bi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meixia Bi collaborates with scholars based in United States, China and Netherlands. Meixia Bi's co-authors include Constantinos Koumenis, John C. Bell, Heather P. Harding, Jaime D. Blais, Bradly G. Wouters, David Ron, Donalyn Scheuner, Diane Fels, James A. Raleigh and Marianne Koritzinsky and has published in prestigious journals such as The EMBO Journal, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Meixia Bi

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth

2005 574 citations Meixia Bi, Christine Naczki et al. The EMBO Journal profile →

Peers

Meixia Bi

EPIDE

SURGE

Lionel Lim United States

Alan J. Diehl United States

Sheng-Cai Lin China

Guili Lian China

Kattria van der Ploeg United States

Duc Thang Nguyên Canada

Jeffrey J. Rodvold United States

Sean P. Ferris United States

Andreas I. Papadakis Canada

Lionel Lim United States

Meixia Bi

423 ×0.7

412 ×0.7

264 ×0.7

EPIDE

183 ×0.8

92 ×0.6

SURGE

Citations per year, relative to Meixia Bi Meixia Bi (= 1×) peers Lionel Lim

Countries citing papers authored by Meixia Bi

Since Specialization

Citations

This map shows the geographic impact of Meixia Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixia Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixia Bi more than expected).

Fields of papers citing papers by Meixia Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixia Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixia Bi. The network helps show where Meixia Bi may publish in the future.

Co-authorship network of co-authors of Meixia Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Meixia Bi. A scholar is included among the top collaborators of Meixia Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixia Bi. Meixia Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Li, Wei, et al.. (2025). Analyzing cropland fragmentation evolution and driving mechanisms in Shandong through MSPA and landscape metrics integration. Scientific Reports. 15(1). 21437–21437.

Hu, Nianping, Christine Naczki, James A. Raleigh, et al.. (2020). ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. UNC Libraries. 1 indexed citations

Waight, Jeremy D., Meixia Bi, David Kilian, et al.. (2020). Abstract 2220: Non-clinical tumor models reveal broad combination potential of ICOS agonist antibodies. Cancer Research. 80(16_Supplement). 2220–2220.

Brett, Sara, Sapna Yadavilli, Laura Seestaller‐Wehr, et al.. (2018). Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody. Annals of Oncology. 29. viii652–viii653. 1 indexed citations

Bhattacharya, Sabyasachi, Paul Bojczuk, David Kilian, et al.. (2018). Evaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade. Annals of Oncology. 29. viii424–viii425.

Yadavilli, Sapna, Tianqian Zhang, Ashleigh Hahn, et al.. (2017). Abstract 1637: ICOS agonism induces potent immune activation and anti-tumor response in non-clinical models. Cancer Research. 77(13_Supplement). 1637–1637. 2 indexed citations

Bi, Meixia, Chris Hopson, Tianqian Zhang, James Smothers, & Axel Hoos. (2016). Abstract A054: In vivo characterization of Ipilimumab T cell modulation and antitumor activity in a tumor bearing humanized NSG mouse model. Cancer Immunology Research. 4(1_Supplement). A054–A054.

Koumenis, Constantinos, Meixia Bi, Jiangbin Ye, Douglas E. Feldman, & Albert C. Koong. (2007). Hypoxia and the Unfolded Protein Response. Methods in enzymology on CD-ROM/Methods in enzymology. 435. 275–293. 29 indexed citations

Little, Joy L., Diane Fels, Meixia Bi, Constantinos Koumenis, & Steven J. Kridel. (2006). PERK signaling, but not eIF2α phosphorylation, protects tumor cells from the effects of Fatty Acid Synthase inhibitors.. Cancer Research. 66. 1190–1191. 1 indexed citations

10.

Bi, Meixia, Christine Naczki, Marianne Koritzinsky, et al.. (2005). ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. The EMBO Journal. 24(19). 3470–3481. 574 indexed citations breakdown →

11.

Blais, Jaime D., Meixia Bi, Heather P. Harding, et al.. (2004). Activating Transcription Factor 4 Is Translationally Regulated by Hypoxic Stress. Molecular and Cellular Biology. 24(17). 7469–7482. 359 indexed citations

12.

Sinclair, Natalie, Wandong Ai, Raktima Raychowdhury, et al.. (2004). Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism. American Journal of Physiology-Gastrointestinal and Liver Physiology. 286(6). G992–G999. 36 indexed citations

13.

Yue, Chunmei, Meixia Bi, Wen Tan, et al.. (2003). Short tandem repeat polymorphism in a novel esophageal cancer‐related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population. International Journal of Cancer. 108(2). 232–236. 23 indexed citations

14.

Cui, Yongping, Jianbo Wang, Xinyu Zhang, et al.. (2003). ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochemical and Biophysical Research Communications. 302(4). 904–915. 52 indexed citations

15.

Bi, Meixia, et al.. (2001). Using Lab On-line to Clone and Identify the Esophageal Cancer Related Gene 4.. PubMed. 33(3). 257–261. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact